A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients
- PMID: 32656711
- PMCID: PMC7354364
- DOI: 10.1007/s10072-020-04591-3
A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients
Abstract
The sudden worldwide outbreak of Coronavirus Disease 2019 (COVID-19) has certainly provided new challenges in the management of acute ischaemic stroke, and the risk-benefit ratio of intravenous thrombolysis in COVID-19 positive patients is not well known. We describe four COVID-19 patients treated with intravenous thrombolysis for acute ischaemic stroke. Although rt-PA administration is the main therapeutic strategy, our patients experienced unpredictable complications and showed atypical features: the overall mortality was very high. In conclusion, in this article, we provide information about these cases and discuss the possible explanation behind this trend.
Keywords: COVID-19; Intravenous thrombolysis; Stroke; rt-PA.
Conflict of interest statement
The authors declare that they have no conflict of interest.
References
-
- Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50:e344–e418. doi: 10.1161/STROKEAHA.118.022606. - DOI - PubMed
-
- Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv 2020.02.22.20026500, 10.1101/2020.02.22.20026500 (accessed 17 Apr 2020)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical